formationbio
Vice President, Engineering
At a Glance
- Location
- NYC, NY; Boston MA
- Experience
- 10+ years
- Compensation
- alary range for this role is: $347,000 - $435,000 Salary ranges are informed by
- Posted
- 2026-03-11T17:17:10-04:00
Key Requirements
Required Skills
Certifications
- GMP
Domain Knowledge
- Automation
- Biotech
- Clinical
- Engineering
- Pharmaceutical
- Regulatory
Benefits & Perks
y, we offer equity, comprehensive benefits, generous perks, hybrid flexibility, an
Requirements
10+ years of experience
in software/data engineering and technical leadership, with a significant background in the Boston biotech or pharma-tech ecosystem.
Biotech Intuition
: You have likely been a VP of Engineering at 2–3 different biotechs and possess a deep understanding of the drug development lifecycle, from Discovery through Phase III.
Proven People Leader
: Experience managing and mentoring a team of 15+ engineers, with a track record of driving results in highly technical, interdisciplinary environments.
Compensation & Benefits
Salary ranges are informed by a number of factors including geographic location. The range provided includes base salary only. In addition to base salary, we offer equity, comprehensive benefits, generous perks, hybrid flexibility, and more. If this range doesn't match your expectations, please still apply because we may have something else for you.
You will receive consideration for employment without regard to race, color, religion, gender, gender identity or expression, sexual orientation, national origin, genetics, disability, age, or veteran status.
Responsibilities
Formation Bio is seeking a bold and forward-thinking Vice President of Engineering to lead and transform our technical capabilities into a strategic driver of clinical and commercial success. This critical leadership role will report to the CTO and serve as a senior thought partner in defining how sophisticated engineering and computational frameworks can fundamentally reshape drug development and asset acquisition.
The ideal candidate is a biotech-native technical leader who understands that our goal is not to build traditional software products, but to develop deep technical capabilities that drive hard insights. You will partner closely with Product to translate complex scientific and operational bottlenecks into high-leverage technology solutions that accelerate workflows and deliver higher-quality insights. You will oversee the engineering behind complex data science analyses - including Real-World Evidence (RWE) platforms, large-scale information ingestion pipelines, and comprehensive modeling - that move the needle for pharma decision-making. You bring the vision and [biotech] experience to ensure our technical foundation supports clinical-stage assets and highly regulated R&D workflows with precision and speed.
Define and execute a technical vision that prioritizes high-leverage computational capabilities over traditional software features, ensuring engineering effort directly increases drug asset quality and value.
Act as a core collaborator for the CTO and leadership team, translating complex clinical and business bottlenecks into scalable engineering solutions.
Embed engineering resources within Business Development, Clinical, and R&D units to leverage technology to address operational needs.
About the Company
Formation Bio is a tech and AI driven pharma company differentiated by radically more efficient drug development.
Advancements in AI and drug discovery are creating more candidate drugs than the industry can progress because of the high cost and time of clinical trials. Recognizing that this development bottleneck may ultimately limit the number of new medicines that can reach patients, Formation Bio, founded in 2016 as TrialSpark Inc., has built technology platforms, processes, and capabilities to accelerate all aspects of drug development and clinical trials. Formation Bio partners, acquires, or in-licenses drugs from pharma companies, research organizations, and biotechs to develop programs past clinical proof of concept and beyond, ultimately helping to bring new medicines to patients. The company is backed by investors across pharma and tech, including a16z, Sequoia, Sanofi, Thrive Capital, Sam Altman, John Doerr, Spark Capital, SV Angel Growth, and others.
You can read more at the following links:
Our Vision for AI in Pharma
Our Current Drug Portfolio
Our Technology & Platform